Atlatl Advisers LLC increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 2.9% during the 2nd quarter, Holdings Channel reports. The fund owned 4,785 shares of the company’s stock after acquiring an additional 133 shares during the period. Atlatl Advisers LLC’s holdings in Cardinal Health were worth $804,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Principal Financial Group Inc. boosted its stake in Cardinal Health by 5.3% during the first quarter. Principal Financial Group Inc. now owns 315,817 shares of the company’s stock worth $43,510,000 after acquiring an additional 15,956 shares in the last quarter. Golden State Wealth Management LLC boosted its stake in Cardinal Health by 569.5% during the first quarter. Golden State Wealth Management LLC now owns 395 shares of the company’s stock worth $54,000 after acquiring an additional 336 shares in the last quarter. North Capital Inc. bought a new position in Cardinal Health during the first quarter worth $83,000. KLP Kapitalforvaltning AS boosted its stake in Cardinal Health by 4.0% during the second quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after acquiring an additional 4,400 shares in the last quarter. Finally, Czech National Bank boosted its stake in Cardinal Health by 5.1% during the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock worth $9,801,000 after acquiring an additional 2,857 shares in the last quarter. 87.17% of the stock is owned by institutional investors.
Insider Buying and Selling
In other news, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares in the company, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the sale, the insider owned 15,431 shares of the company’s stock, valued at $2,298,293.14. This trade represents a 64.59% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 271,676 shares of company stock valued at $40,489,525 over the last 90 days. 0.12% of the stock is currently owned by company insiders.
Cardinal Health Price Performance
Cardinal Health (NYSE:CAH – Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $2.03 by $0.05. The company had revenue of $60.16 billion during the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st were issued a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio is currently 31.63%.
Wall Street Analyst Weigh In
CAH has been the topic of several research analyst reports. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research note on Tuesday, August 12th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Weiss Ratings restated a “buy (b)” rating on shares of Cardinal Health in a report on Friday. Evercore ISI lowered their price objective on shares of Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Finally, Argus set a $189.00 price objective on shares of Cardinal Health in a report on Friday, August 22nd. Twelve investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $166.00.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- What is a Microcap Stock? Everything You Need to Know
- Tractor Supply Stock Looks Like a Buy-and-Hold Winner
- Following Congress Stock Trades
- 3 Stocks Well Below 52-Week Highs Poised for a Q4 Rebound
- Top Stocks Investing in 5G Technology
- Big Banks Are Setting the Tone as Earnings Season Kicks Off
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
